SPDR S&P Aerospace & Defense ETF (XAR)
- Previous Close
135.17 - Open
135.84 - Bid --
- Ask --
- Day's Range
133.52 - 136.11 - 52 Week Range
108.32 - 142.78 - Volume
82,273 - Avg. Volume
74,180 - Net Assets 2.12B
- NAV 135.16
- PE Ratio (TTM) 29.84
- Yield 0.55%
- YTD Daily Total Return -0.07%
- Beta (5Y Monthly) 0.98
- Expense Ratio (net) 0.35%
In seeking to track the performance of the S&P Aerospace & Defense Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the aerospace and defense segment of the S&P Total Market Index ("S&P TMI").
SPDR State Street Global Advisors
Fund Family
Industrials
Fund Category
2.12B
Net Assets
2011-09-28
Inception Date
Performance Overview: XAR
Trailing returns as of 4/23/2024. Category is Industrials.
People Also Watch
Holdings: XAR
Top 10 Holdings (39.04% of Total Assets)
Sector Weightings
Recent News: XAR
Research Reports: XAR
Analyst Report: Biogen Inc.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel multiple sclerosis drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is copromoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with Sobi) were spun off as part of Bioverativ in 2017. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (post-partum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology-related fields.
RatingPrice TargetMOS: What does Argus have to say about MOS?
MOSAIC CO/THE has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetAnalyst Report: ASML Holding N.V.
ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.
RatingPrice TargetAWR: What does Argus have to say about AWR?
AMERICAN STATES WATER CO has an Investment Rating of HOLD; a target price of $74.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target